• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens.

作者信息

Hohloch K, Zeynalova S, Held G, Ziepert M, Loeffler M, Wulf G, Schmitz N, Pfreundschuh M, Trümper L

机构信息

Department of Hematology and Medical Oncology, Georg August University, Goettingen, Germany.

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

出版信息

Leukemia. 2014 Nov;28(11):2260-3. doi: 10.1038/leu.2014.213. Epub 2014 Jul 9.

DOI:10.1038/leu.2014.213
PMID:25005242
Abstract
摘要

相似文献

1
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens.采用类CHOP方案治疗的年轻侵袭性非霍奇金淋巴瘤患者疗效优异。
Leukemia. 2014 Nov;28(11):2260-3. doi: 10.1038/leu.2014.213. Epub 2014 Jul 9.
2
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.伊布替尼联合利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松（R-CHOP）治疗初治 CD20 阳性 B 细胞非霍奇金淋巴瘤患者：一项非随机、1b 期研究。
Lancet Oncol. 2014 Aug;15(9):1019-26. doi: 10.1016/S1470-2045(14)70311-0. Epub 2014 Jul 17.
3
Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.侵袭性非霍奇金淋巴瘤的有效免疫化疗
Semin Oncol. 2004 Feb;31(1 Suppl 2):7-11.
4
A meta-analysis on Rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China.利妥昔单抗联合CHOP化疗治疗中国非霍奇金淋巴瘤的荟萃分析。
Saudi Med J. 2011 Jul;32(7):675-8.
5
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.影响 HIV 相关非霍奇金淋巴瘤患者结局的治疗因素：1546 例患者的汇总分析。
Blood. 2013 Nov 7;122(19):3251-62. doi: 10.1182/blood-2013-04-498964. Epub 2013 Sep 6.
6
Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support.采用密集剂量利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松联合粒细胞-巨噬细胞集落刺激因子和聚乙二醇化粒细胞集落刺激因子作为支持的侵袭性非霍奇金淋巴瘤一线免疫化疗。
Leuk Lymphoma. 2012 Oct;53(10):1929-33. doi: 10.3109/10428194.2012.679264. Epub 2012 Apr 23.
7
Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.一线使用环磷酰胺、阿霉素、长春新碱和泼尼松（CHOP）或CHOP联合利妥昔单抗（R-CHOP）治疗的非霍奇金淋巴瘤患者的心血管不良事件：一项系统评价和荟萃分析。
Lancet Haematol. 2020 Apr;7(4):e295-e308. doi: 10.1016/S2352-3026(20)30031-4. Epub 2020 Mar 2.
8
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.剂量调整 EPOCH-利妥昔单抗治疗非霍奇金淋巴瘤的相关并发症。
Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):781-787. doi: 10.1016/j.clml.2018.08.014. Epub 2018 Aug 29.
9
AIDS-lymphoma (ARL): one more step along the way.艾滋病相关性淋巴瘤（ARL）：又向前迈进了一步。
Blood. 2013 Nov 7;122(19):3244-6. doi: 10.1182/blood-2013-09-526350.
10
A treatment for activated B-cell-like DLBCL?一种针对活化B细胞样弥漫性大B细胞淋巴瘤的治疗方法？
Lancet Oncol. 2014 Aug;15(9):916-7. doi: 10.1016/S1470-2045(14)70327-4. Epub 2014 Jul 17.

引用本文的文献

1
Real-World Outcomes of Adolescents and Young Adults with Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Cohort Study.弥漫性大 B 细胞淋巴瘤青少年及年轻成人的真实世界结局：一项多中心回顾性队列研究。
J Adolesc Young Adult Oncol. 2024 Apr;13(2):323-330. doi: 10.1089/jayao.2023.0095. Epub 2023 Oct 16.

本文引用的文献

1
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).常规化疗（CHOEP-14）联合利妥昔单抗或大剂量化疗（MegaCHOEP）联合利妥昔单抗治疗侵袭性 B 细胞淋巴瘤的年轻高危患者：一项开放标签、随机、III 期试验（DSHNHL 2002-1）。
Lancet Oncol. 2012 Dec;13(12):1250-9. doi: 10.1016/S1470-2045(12)70481-3. Epub 2012 Nov 16.
2
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.患者诊断时的年龄与弥漫性大 B 细胞淋巴瘤的分子特征有关。
Blood. 2012 Feb 23;119(8):1882-7. doi: 10.1182/blood-2011-10-388470. Epub 2012 Jan 11.
3
Malignant hematologic diseases in adolescents and young adults.青少年和年轻成人的恶性血液病。
Blood. 2011 Jun 2;117(22):5803-15. doi: 10.1182/blood-2010-12-283093. Epub 2011 Mar 11.
4
Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.青少年非霍奇金淋巴瘤：378 例青少年 NHL 患者按儿科 NHL-BFM 方案治疗的经验。
Leukemia. 2011 Jan;25(1):153-60. doi: 10.1038/leu.2010.245. Epub 2010 Oct 29.
5
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma.大剂量化疗联合自体造血干细胞移植治疗高危弥漫大 B 细胞淋巴瘤：利妥昔单抗的应用价值。
Ann Oncol. 2010 Nov;21(11):2255-2261. doi: 10.1093/annonc/mdq235. Epub 2010 May 5.
6
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials.基于人群的前瞻性临床试验中治疗的儿童成熟B细胞淋巴瘤的分子特征分析。
Blood. 2008 Aug 15;112(4):1374-81. doi: 10.1182/blood-2008-01-136465. Epub 2008 May 28.
7
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
Ann Oncol. 2008 Mar;19(3):538-44. doi: 10.1093/annonc/mdm497. Epub 2008 Jan 22.
8
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).剂量递增的CHOEP方案治疗侵袭性非霍奇金淋巴瘤年轻患者：II. 德国高级别非霍奇金淋巴瘤研究组（DSHNHL）随机高剂量CHOEP试验结果
Ann Oncol. 2008 Mar;19(3):545-52. doi: 10.1093/annonc/mdm514. Epub 2007 Dec 6.
9
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.基于转录组和基因组分析的伯基特淋巴瘤生物学定义
N Engl J Med. 2006 Jun 8;354(23):2419-30. doi: 10.1056/NEJMoa055351.
10
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.在预后良好的年轻弥漫性大B细胞淋巴瘤患者中，CHOP样化疗联合利妥昔单抗对比单纯CHOP样化疗：美罗华国际试验（MInT）组的一项随机对照试验
Lancet Oncol. 2006 May;7(5):379-91. doi: 10.1016/S1470-2045(06)70664-7.